| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Peter Hohenstein | Q41783681 |
| P2093 | author name string | Eve Miller-Hodges | |
| P2860 | cites work | Hallmarks of Cancer: The Next Generation | Q22252312 |
| WT1 is a key regulator of podocyte function: reduced expression levels cause crescentic glomerulonephritis and mesangial sclerosis | Q24292676 | ||
| PINCH1 is transcriptional regulator in podocytes that interacts with WT1 and represses podocalyxin expression | Q24296236 | ||
| Regeneration of glomerular podocytes by human renal progenitors | Q24308871 | ||
| Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence | Q24309539 | ||
| WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes | Q24596062 | ||
| The epithelial-mesenchymal transition generates cells with properties of stem cells | Q24650786 | ||
| The Wilms' tumor suppressor protein WT1 is processed by the serine protease HtrA2/Omi | Q24655084 | ||
| Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus | Q28236741 | ||
| Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping | Q28236877 | ||
| WT1 and glomerular diseases | Q28259503 | ||
| The many facets of the Wilms' tumour gene, WT1 | Q28264516 | ||
| WT1 the oncogene: a tale of death and HtrA | Q28272033 | ||
| WAGR syndrome: a clinical review of 54 cases | Q28275152 | ||
| The Wilms' tumour protein (WT1) shuttles between nucleus and cytoplasm and is present in functional polysomes | Q28505624 | ||
| Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4 | Q28508296 | ||
| Two splice variants of the Wilms' tumor 1 gene have distinct functions during sex determination and nephron formation | Q28509874 | ||
| WT-1 is required for early kidney development | Q28512266 | ||
| A zinc finger truncation of murine WT1 results in the characteristic urogenital abnormalities of Denys-Drash syndrome | Q28584838 | ||
| The Wilms' tumor gene Wt1 is required for normal development of the retina | Q28590668 | ||
| Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways | Q29615855 | ||
| Evidence that fibroblasts derive from epithelium during tissue fibrosis | Q29616581 | ||
| A high-powered view of the filtration barrier | Q30665384 | ||
| Wilms' tumor suppressor (WT1) is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer's disease | Q30975987 | ||
| Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis | Q33556248 | ||
| De novo expression of podocyte proteins in parietal epithelial cells during experimental glomerular disease | Q33727815 | ||
| Antagonism of WT1 activity by protein self-association. | Q33756936 | ||
| A novel WT1 gene mutation in a three-generation family with progressive isolated focal segmental glomerulosclerosis | Q33769998 | ||
| Presence of WT1, the Wilm's tumor suppressor gene product, in nuclear poly(A)(+) ribonucleoprotein | Q33883341 | ||
| An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor | Q34189532 | ||
| The candidate Wilms' tumour gene is involved in genitourinary development | Q34189819 | ||
| Wilms tumor 1 (WT1) regulates KRAS-driven oncogenesis and senescence in mouse and human models. | Q34248627 | ||
| Epidemiology of Wilms tumor | Q34305834 | ||
| Life, sex, and WT1 isoforms--three amino acids can make all the difference | Q34348689 | ||
| Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computerized mutation database | Q34385164 | ||
| Wt1 ablation and Igf2 upregulation in mice result in Wilms tumors with elevated ERK1/2 phosphorylation | Q34428960 | ||
| Donor splice-site mutations in WT1 are responsible for Frasier syndrome | Q34449327 | ||
| A clinical overview of WT1 gene mutations | Q34738955 | ||
| Wilms' tumours: about tumour suppressor genes, an oncogene and a chameleon gene | Q35095712 | ||
| CTNNB1 mutations and overexpression of Wnt/beta-catenin target genes in WT1-mutant Wilms' tumors | Q35103587 | ||
| TGF-beta1 reduces Wilms' tumor suppressor gene expression in podocytes | Q35218235 | ||
| A new aspect of the molecular pathogenesis of paroxysmal nocturnal hemoglobinuria | Q35670980 | ||
| New insights into epithelial-mesenchymal transition in kidney fibrosis | Q36010095 | ||
| Transcriptional regulation by WT1 in development. | Q36229114 | ||
| Wilms' tumour: connecting tumorigenesis and organ development in the kidney | Q36234726 | ||
| Surveillance for Wilms tumour in at-risk children: pragmatic recommendations for best practice | Q36542374 | ||
| Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria | Q36559707 | ||
| The Wnt/beta-catenin pathway in Wilms tumors and prostate cancers | Q36907358 | ||
| Mesothelium contributes to vascular smooth muscle and mesenchyme during lung development. | Q36938543 | ||
| Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition | Q36985824 | ||
| Recruitment of podocytes from glomerular parietal epithelial cells | Q37086632 | ||
| New insights into the function of the Wilms tumor suppressor gene WT1 in podocytes | Q37127104 | ||
| Role of the Wilms' tumour transcription factor, Wt1, in blood vessel formation | Q37340320 | ||
| RNA binding by the Wilms tumor suppressor zinc finger proteins. | Q37426489 | ||
| Effects of TGF-beta on podocyte growth and disease progression in proliferative podocytopathies | Q37698872 | ||
| WT1 (Wilms' tumor gene 1): biology and cancer immunotherapy | Q37731720 | ||
| The molecular mediators of type 2 epithelial to mesenchymal transition (EMT) and their role in renal pathophysiology. | Q37760963 | ||
| Activation of the TGF-beta/Smad signaling pathway in focal segmental glomerulosclerosis | Q38519222 | ||
| Wilms tumor cells with WT1 mutations have characteristic features of mesenchymal stem cells and express molecular markers of paraxial mesoderm | Q39747265 | ||
| Actin: a novel interaction partner of WT1 influencing its cell dynamic properties | Q39766194 | ||
| Mechanisms of angiotensin II signaling on cytoskeleton of podocytes | Q39942955 | ||
| The molecular and functional phenotype of glomerular podocytes reveals key features of contractile smooth muscle cells | Q39953304 | ||
| Wilms' tumor protein (-KTS) modulates renin gene transcription. | Q39979771 | ||
| Identification of novel Wilms' tumor suppressor gene target genes implicated in kidney development | Q40146414 | ||
| The major podocyte protein nephrin is transcriptionally activated by the Wilms' tumor suppressor WT1. | Q40484861 | ||
| The Wilms’ tumour suppressor protein, WT1, undergoes CRM1‐independent nucleocytoplasmic shuttling | Q40620494 | ||
| Wnt-4 regulation by the Wilms' tumour suppressor gene, WT1. | Q40722568 | ||
| WT1 regulates the expression of the major glomerular podocyte membrane protein Podocalyxin | Q40767021 | ||
| Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing | Q41347006 | ||
| Sequential WT1 and CTNNB1 mutations and alterations of beta-catenin localisation in intralobar nephrogenic rests and associated Wilms tumours: two case studies | Q41809711 | ||
| Wt1 controls retinoic acid signalling in embryonic epicardium through transcriptional activation of Raldh2. | Q42052856 | ||
| Different CTNNB1 mutations as molecular genetic proof for the independent origin of four Wilms tumours in a patient with a novel germ line WT1 mutation | Q42550921 | ||
| Wt1 is required for cardiovascular progenitor cell formation through transcriptional control of Snail and E-cadherin. | Q42945812 | ||
| A wt1-controlled chromatin switching mechanism underpins tissue-specific wnt4 activation and repression | Q43221537 | ||
| The wt1-heterozygous mouse; a model to study the development of glomerular sclerosis | Q44536833 | ||
| Murine Denys-Drash syndrome: evidence of podocyte de-differentiation and systemic mediation of glomerulosclerosis | Q44547374 | ||
| Characteristics and outcomes of children with the Wilms tumor-Aniridia syndrome: a report from the National Wilms Tumor Study Group | Q44573108 | ||
| Differentiated human podocytes endogenously express an inhibitory isoform of vascular endothelial growth factor (VEGF165b) mRNA and protein | Q44673718 | ||
| Expression of Wilms' tumor suppressor in the liver with cirrhosis: relation to hepatocyte nuclear factor 4 and hepatocellular function | Q45863258 | ||
| Wt1 and retinoic acid signaling are essential for stellate cell development and liver morphogenesis | Q46889320 | ||
| Functional symbiosis between endothelium and epithelial cells in glomeruli | Q46902679 | ||
| The dysregulated glomerular cell growth in Denys-Drash syndrome | Q47251228 | ||
| Impaired glomerular maturation and lack of VEGF165b in Denys-Drash syndrome | Q47813520 | ||
| The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo. | Q48369257 | ||
| The eponym "Wilms": a reminder of a surgeon's lifelong contributions to medicine | Q50253196 | ||
| Small glomeruli in WAGR (Wilms Tumor, Aniridia, Genitourinary Anomalies and Mental Retardation) syndrome. | Q51903202 | ||
| Analysis of early nephron patterning reveals a role for distal RV proliferation in fusion to the ureteric tip via a cap mesenchyme-derived connecting segment. | Q51933152 | ||
| Development of an siRNA-based method for repressing specific genes in renal organ culture and its use to show that the Wt1 tumour suppressor is required for nephron differentiation. | Q52097211 | ||
| The Wilms tumor suppressor gene wt1 is required for development of the spleen. | Q52174780 | ||
| YAC transgenic analysis reveals Wilms' tumour 1 gene activity in the proliferating coelomic epithelium, developing diaphragm and limb. | Q52176765 | ||
| Management of Wilms tumors in Drash and Frasier syndromes. | Q53208087 | ||
| Epithelial-mesenchymal transition as a potential explanation for podocyte depletion in diabetic nephropathy. | Q54472919 | ||
| WT1 mutations in Meacham syndrome suggest a coelomic mesothelial origin of the cardiac and diaphragmatic malformations | Q55671351 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 229-240 | |
| P577 | publication date | 2011-09-29 | |
| P1433 | published in | Journal of Pathology | Q400296 |
| P1476 | title | WT1 in disease: shifting the epithelial-mesenchymal balance | |
| P478 | volume | 226 |
| Q36574746 | Adiponectin promotes functional recovery after podocyte ablation |
| Q41204430 | Blood-testis barrier integrity depends on Pin1 expression in Sertoli cells |
| Q36200428 | Clinically relevant subsets identified by gene expression patterns support a revised ontogenic model of Wilms tumor: a Children's Oncology Group Study |
| Q30660201 | Deducing the stage of origin of Wilms' tumours from a developmental series of Wt1-mutant mice |
| Q27728005 | Denys-Drash syndrome associated WT1 glutamine 369 mutants have altered sequence-preferences and altered responses to epigenetic modifications |
| Q28281068 | Distinct sites of renal fibrosis in Crim1 mutant mice arise from multiple cellular origins |
| Q90558495 | EGR-mediated control of STIM expression and function |
| Q37505694 | Evidence from a mouse model that epithelial cell migration and mesenchymal-epithelial transition contribute to rapid restoration of uterine tissue integrity during menstruation |
| Q37946790 | Omnis cellula e cellula revisited: cell biology as the foundation of pathology |
| Q38261392 | One shall become two: Separation of the esophagus and trachea from the common foregut tube |
| Q28396403 | Pleural mesothelial cells in pleural and lung diseases |
| Q38995226 | Recent findings on the genetics of disorders of sex development |
| Q34612490 | The transcription factors Tbx18 and Wt1 control the epicardial epithelial-mesenchymal transition through bi-directional regulation of Slug in murine primary epicardial cells |
| Q35173260 | The yin and yang of kidney development and Wilms' tumors |
| Q28507766 | Transcriptional regulation by the Wilms tumor protein, Wt1, suggests a role of the metalloproteinase Adamts16 in murine genitourinary development |
| Q50971977 | Turning back the Wheel: Inducing Mesenchymal to Epithelial Transition via Wilms Tumor 1 Knockdown in Human Mesothelioma Cell Lines to Influence Proliferation, Invasiveness, and Chemotaxis. |
| Q40359208 | WT1 Expression in Adult Acute Myeloid Leukemia: Assessing its Presence, Magnitude and Temporal Changes as Prognostic Factors. |
| Q42376448 | WT1 Is Necessary for the Proliferation and Migration of Cells of Renin Lineage Following Kidney Podocyte Depletion. |
| Q50498738 | WT1 Mutation in Childhood Cancer. |
| Q58093530 | WT1 expression in vessels varies with histopathological grade in tumour-bearing and control tissue from patients with breast cancer |
| Q47369729 | WT1 loss attenuates the TP53-induced DNA damage response in T-cell acute lymphoblastic leukemia |
| Q51279116 | Wilms Tumor 1 protein is not expressed in oral lymphangiomas. |
| Q35002935 | Wilms tumor suppressor, WT1, suppresses epigenetic silencing of the β-catenin gene |
| Q28396314 | Wilms' tumor 1 (Wt1) regulates pleural mesothelial cell plasticity and transition into myofibroblasts in idiopathic pulmonary fibrosis |
| Q38720362 | Wilms' tumor gene 1 silencing inhibits proliferation of human osteosarcoma MG-63 cell line by cell cycle arrest and apoptosis activation. |
| Q26851512 | Wt-1 Expression Linked to Nitric Oxide Availability during Neonatal Obstructive Nephropathy |
| Q38163312 | Wt1 in the kidney--a tale in mouse models. |
Search more.